Clinics

Comments
The t(16;21)(q24;q22) is mainly found in t-MDS /t-AML (14/16 cases (1-10)), following breast cancer therapy (five cases (7, 8, 10) ), lymphoma (four cases), Hodgkin's disease, lung and oviductal cancers and AML-M3 (one case each). Trisomy 8, the secondary change found in the current case, is also reported in most if not all patients with previous breast cancer (7, 8, 10) . To note, three out of five patients had lymphoid positive antigenes (5,7, current case). All of the nine patients whose treatments were reported (3-9), plus the current case, were treated with a combination of alkylating agents and topoisomerase II inhibitors, +/-radiotherapy. 
